Literature DB >> 10630411

STAT5b mediates the GH-induced expression of SOCS-2 and SOCS-3 mRNA in the liver.

H W Davey1, M J McLachlan, R J Wilkins, D J Hilton, T E Adams.   

Abstract

Suppressor of cytokine signalling (SOCS) proteins act as part of a classical negative feedback loop regulating cytokine signal transduction. Expression of SOCS proteins is induced in response to cytokines and down-regulates the cytokine signal by inhibiting the JAK/STAT pathway. Growth hormone (GH) was previously shown to induce strong transient expression of SOCS-3 and to a lesser extent CIS, SOCS-1 and SOCS-2 in mouse liver (Adams, T.E., Hansen, J.A., Starr, R., Nicola, N.A., Hilton, D.J., Billestrup, N., 1998. Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signalling. J. Biol. Chem. 273, 1285-1287.). In this work we have compared GH-induced SOCS gene expression in wild-type and STAT5b-deficient mice, and show that STAT5b is required for the induction of SOCS-2 and SOCS-3 in liver. In contrast, the absence of STAT5b has no effect on the GH-induced expression of CIS and SOCS-2 mRNA in the mammary gland. Suprisingly, there is no activation of SOCS-3 expression in mammary glands of wild-type and STAT5b mutant mice following GH administration. These results highlight both tissue- and factor-specific differences in the regulation of SOCS gene expression by STAT5a/b.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10630411     DOI: 10.1016/s0303-7207(99)00175-6

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  27 in total

Review 1.  The central role of SOCS-3 in integrating the neuro-immunoendocrine interface.

Authors:  C J Auernhammer; S Melmed
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

2.  Peginesatide and erythropoietin stimulate similar erythropoietin receptor-mediated signal transduction and gene induction events.

Authors:  Jennifer M Green; Karen Leu; Angela Worth; Richard B Mortensen; David K Martinez; Peter J Schatz; Don M Wojchowski; Peter R Young
Journal:  Exp Hematol       Date:  2012-03-06       Impact factor: 3.084

3.  Lineage-Specific and Non-specific Cytokine-Sensing Genes Respond Differentially to the Master Regulator STAT5.

Authors:  Xianke Zeng; Michaela Willi; Ha Youn Shin; Lothar Hennighausen; Chaochen Wang
Journal:  Cell Rep       Date:  2016-12-20       Impact factor: 9.423

4.  Defining the epigenetic actions of growth hormone: acute chromatin changes accompany GH-activated gene transcription.

Authors:  Dennis J Chia; Peter Rotwein
Journal:  Mol Endocrinol       Date:  2010-08-11

5.  Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.

Authors:  D Lejeune; J B Demoulin; J C Renauld
Journal:  Biochem J       Date:  2001-01-01       Impact factor: 3.857

6.  LEPROT and LEPROTL1 cooperatively decrease hepatic growth hormone action in mice.

Authors:  Thierry Touvier; Françoise Conte-Auriol; Olivier Briand; Céline Cudejko; Réjane Paumelle; Sandrine Caron; Eric Baugé; Yves Rouillé; Jean-Pierre Salles; Bart Staels; Bernard Bailleul
Journal:  J Clin Invest       Date:  2009-11-09       Impact factor: 14.808

Review 7.  Expression and function of anti-inflammatory interleukins: the other side of the vascular response to injury.

Authors:  Anthony A Cuneo; Michael V Autieri
Journal:  Curr Vasc Pharmacol       Date:  2009-07       Impact factor: 2.719

Review 8.  Modulation of growth hormone receptor abundance and function: roles for the ubiquitin-proteasome system.

Authors:  Stuart J Frank; Serge Y Fuchs
Journal:  Biochim Biophys Acta       Date:  2008-06-09

Review 9.  Mechanistic aspects of crosstalk between GH and PRL and ErbB receptor family signaling.

Authors:  Stuart J Frank
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-31       Impact factor: 2.673

10.  Heterogeneous expression of suppressor of cytokine signalling 2 (SOCS-2) in liver tissue.

Authors:  Sebastian Zellmer; Stephan Sickinger; Wolfgang Schmidt-Heck; Reinhard Guthke; Rolf Gebhardt
Journal:  J Anat       Date:  2009-05-14       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.